Four kinds of antibody positive paraneoplastic limbic encephalitis: A rare case report
- PMID: 36926412
- PMCID: PMC10012000
- DOI: 10.12998/wjcc.v11.i7.1586
Four kinds of antibody positive paraneoplastic limbic encephalitis: A rare case report
Abstract
Background: It is not uncommon to develop autoimmune encephalitis and paraneoplastic neurological syndromes (PNS). 4 kinds of antibody-positive autoimmune paraneoplastic limbic encephalitis (PLE) have not been reported.
Case summary: PNS are distant effects of cancer on the nervous system, rather than syndromes in which cancer directly invades and metastasizes to the nerves and/or muscle tissues. If the limbic lobe system of the brain is involved, this will result in PLE. The detection of patients with PNS is challenging since tumors that cause paraneoplastic neurologic disorders are often asymptomatic, obscure, and thus easily misdiagnosed or missed. Currently, single- or double-antibody-positive paraneoplastic marginal encephalitis has been reported. However, no cases of three or more-antibody-positive cases have been reported. Here, we report a case of PLE that is anti-collapsing response-mediator protein-5, anti-neuronal nuclear antibody-type 1, anti-aminobutyric acid B receptor, and anti-glutamate deglutase positive, and address relevant literature to improve our understanding of the disease.
Conclusion: This article reports on the management of a case of PLE with four positive antibodies, a review of the literature, in order to raise awareness among clinicians.
Keywords: Case report; Paraneoplastic limbic encephalitis; anti-aminobutyric acid B receptor; anti-collapsing response-mediator protein-5; anti-glutamate deglutase; anti-neuronal nuclear antibody-type 1.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Figures



Similar articles
-
Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: A case report.Front Immunol. 2022 Jul 28;13:955170. doi: 10.3389/fimmu.2022.955170. eCollection 2022. Front Immunol. 2022. PMID: 35967304 Free PMC article.
-
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.Brain. 2000 Jul;123 ( Pt 7):1481-94. doi: 10.1093/brain/123.7.1481. Brain. 2000. PMID: 10869059 Clinical Trial.
-
Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report.Mol Clin Oncol. 2017 Aug;7(2):259-262. doi: 10.3892/mco.2017.1311. Epub 2017 Jun 29. Mol Clin Oncol. 2017. PMID: 28781798 Free PMC article.
-
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. J Neural Transm (Vienna). 2014. PMID: 25081016 Review.
-
Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.Curr Oncol Rep. 2018 Nov 10;20(11):92. doi: 10.1007/s11912-018-0721-y. Curr Oncol Rep. 2018. PMID: 30415318 Review.
Cited by
-
Ataxia-Parkinsonism in a Patient With Double-Positive Anti-Hu and Anti-NMDAR Antibodies.Neurohospitalist. 2025 May 19:19418744251342295. doi: 10.1177/19418744251342295. Online ahead of print. Neurohospitalist. 2025. PMID: 40406738 Free PMC article.
References
-
- Jain A, Balice-Gordon R. Cellular, synaptic, and circuit effects of antibodies in autoimmune CNS synaptopathies. Handb Clin Neurol . 2016;133:77–93. - PubMed
-
- Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, Ritacco DG, Grisold W, Meaney BF, Alcalá C, Sillevis-Smitt P, Titulaer MJ, Balice-Gordon R, Graus F, Dalmau J. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol . 2014;13:276–286. - PMC - PubMed
-
- Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med . 2018;378:840–851. - PubMed
-
- Senties-Madrid H, Vega-Boada F. Paraneoplastic syndromes associated with anti-Hu antibodies. Isr Med Assoc J . 2001;3:94–103. - PubMed
Publication types
LinkOut - more resources
Full Text Sources